A PET study of tiagabine treatment implicates ventral medial prefrontal cortex in generalized social anxiety disorder.
about
Preliminary evidence of white matter abnormality in the uncinate fasciculus in generalized social anxiety disorderCortical and subcortical gamma amino acid butyric acid deficits in anxiety and stress disorders: Clinical implicationsBiological predictors of pharmacological therapy in anxiety disordersAmplitude variability over trials in hemodynamic responses in adolescents with ADHD: The role of the anterior default mode network and the non-specific role of the striatumFunctional network dysfunction in anxiety and anxiety disordersBiological markers for anxiety disorders, OCD and PTSD - a consensus statement. Part I: Neuroimaging and genetics.Resting amygdala and medial prefrontal metabolism predicts functional activation of the fear extinction circuit.Modulation of resting-state amygdala-frontal functional connectivity by oxytocin in generalized social anxiety disorder.The neurocircuitry of fear, stress, and anxiety disordersNeural response to eye contact and paroxetine treatment in generalized social anxiety disorderExamining gray matter structures associated with individual differences in global life satisfaction in a large sample of young adultsCorticolimbic brain reactivity to social signals of threat before and after sertraline treatment in generalized social phobiaNeuroimaging predictors of treatment response in anxiety disorders.Drug interactions involving the new second- and third-generation antiepileptic drugs.Recent advances in the brain imaging of social anxiety disorder.Neurobiological correlates of social anxiety disorder: an update.Toward the application of functional neuroimaging to individualized treatment for anxiety and depression.Don't ask, don't tell: a systematic review of the extent to which participant characteristics are reported in social anxiety treatment studies.Cognitive behavioural therapy attenuates the enhanced early facial stimuli processing in social anxiety disorders: an ERP investigation.Resting regional brain metabolism in social anxiety disorder and the effect of moclobemide therapy.Medial frontal hyperactivity to sad faces in generalized social anxiety disorder and modulation by oxytocin.
P2860
Q24654915-C902B952-5F75-41BD-8761-8B5B75197D39Q26750907-9DB4A468-634C-40AF-A98E-4684A7EAC837Q26781100-9F2D303D-4CFD-4B7D-A463-0F2D87C798B1Q27304901-0290E127-4B67-49B1-BC45-DE894FDC79C0Q28728137-B24A7C42-CEB2-4191-8EC3-4740D62DEB67Q31114020-3E06099A-C0A9-44A3-AD2B-3C3D71C381CAQ33841739-9DFD1D9A-392B-404C-B476-3DCF291EE48AQ33923562-8A4EEC73-95DB-4C69-B2A8-132797493463Q34660882-7E66496E-94D5-4A45-B989-2B326C0AF7C0Q35591557-6153C386-7C8B-49E9-836A-A322D7670703Q35790477-3EDCD420-F5E2-4101-8A92-C54B8039C82FQ36569739-144869A1-23DE-4624-B494-CC4B2C14200FQ37112952-17B8E72F-2F08-46C6-A57B-10EB0F871E83Q37658910-9A9DAC0D-3F70-43FC-965E-7BCC04313575Q38067311-9914EA2B-BC88-4DAB-8037-4BCB7D666A79Q38191310-CE3AA7C5-62F9-4DF5-A616-8FC2C543562DQ38269358-FE29F8A8-5FA9-49F3-BBA2-80E4A051F601Q38686261-63B2B4E2-A35E-4FF5-8E71-324EAB8E9FC9Q42086702-C1D2AD2E-DD2E-4AB0-AD81-75D5748BEFC7Q46930049-2191F9F7-338C-4863-82C8-83780633B798Q48843009-589853C0-83EF-4029-95B6-E746DD0AA16C
P2860
A PET study of tiagabine treatment implicates ventral medial prefrontal cortex in generalized social anxiety disorder.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
A PET study of tiagabine treat ...... lized social anxiety disorder.
@en
A PET study of tiagabine treat ...... lized social anxiety disorder.
@nl
type
label
A PET study of tiagabine treat ...... lized social anxiety disorder.
@en
A PET study of tiagabine treat ...... lized social anxiety disorder.
@nl
prefLabel
A PET study of tiagabine treat ...... lized social anxiety disorder.
@en
A PET study of tiagabine treat ...... lized social anxiety disorder.
@nl
P2093
P2860
P50
P356
P1476
A PET study of tiagabine treat ...... lized social anxiety disorder.
@en
P2093
Alan J Fischman
Candice Chow
Darin D Dougherty
John J Worthington
Karleyton C Evans
Mark H Pollack
Naomi M Simon
Scott L Rauch
P2860
P2888
P304
P356
10.1038/NPP.2008.69
P407
P577
2008-06-04T00:00:00Z
P5875
P6179
1022359946